Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma patient's risk of dying.
... production.
"The worst outcome of long-term myelosuppression for indolent B cell lymphoma patients is myelodysplastic syndrome," Samaniego said. "In this study, out of 80 patients, none developed ...
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as front-line treatment remain in remission seven years later, researchers have reported.
... study team at Yale also looked at subgroups of lymphoma patients, and found the strongest link between wine consumption ... diffuse large B-cell lymphoma. These patients had a 40 to 50 percent reduced risk ...
Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin's lymphoma patients, according to an epidemiology study.
... Patients (HELP) trial, a three-year study led by Kerry Courneya, Canada Research ... designed to look at this issue, but it at least suggests that lymphoma patients can achieve important health and quality ...
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
... antibody used in conjunction with radioactive medications to treat non-Hodgkin's lymphoma patients who have relapsed after treatment or for those with slow-growing forms of the disease such as ...
Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. At the ESMO Conference ...
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 ...
... treatments for diffuse large B-cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic ... refractory B-cell non-Hodgkin lymphoma. The patients were divided into three groups: those with diffuse ...
... , diffuse large B-cell lymphoma and follicular lymphoma. Both are cancers of the immune system. ... lead researcher on the Mayo study.
"One in five lymphoma patients take cholesterol-lowering statins; ...
... week of rest per cycle of treatment. Patients also received vitamin B12 and folic acid ... colleagues identified the unique activity of pralatrexate in patients with lymphoma. Dr. O'Connor has continued ...
... works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma.
HOUSTON, Dec. 15 (UPI) -- U.S. medical scientists say they've found indolent B cell lymphoma patients respond well to a new three-drug combination therapy.
